skip to content

Clinical Trials

MainTitle

Impact of Screening Patients With HIV for Kidney Disease

This study has been withdrawn
Sponsor
University of Mississippi Medical Center


Information provided by (Responsible Party)
University of Mississippi Medical Center
ClinicalTrials.gov Identifier
NCT00392132

First received: October 23, 2006
Last updated: November 24, 2008
Last Verified: November 2008
History of Changes
Purpose

Purpose

The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. This study looks at the effect of this new screening program. Our Hypothesis is that screening for kidney disease is a cost effective and important addition to the care of patients with HIV.

Condition
HIV Infections
Renal Insufficiency, Chronic
Proteinuria

Study Type: Observational
Official Title: Impact of Screening Patients With HIV for Kidney Disease

Further study details as provided by University of Mississippi Medical Center:

Estimated Enrollment: 1400
Study Start Date: October 2005
Estimated Study Completion Date: October 2006
Estimated Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)

Detailed Description:

The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. However nobody knows for sure whether this will help doctors take better care of patient with HIV.
This study looks at the effect of this new screening program. We want to see how frequently abnormalities are seen on screening, how frequently certain kidney diseases are diagnosed, how often patients are referred to a nephrologist and how often a patient's management is changed by the screening. We will also estimate the cost-benefit ratio of the screening. We will review patient charts to determine what has happened in each case where screening was conducted.
This study will not involve any additional testing.
The benefit of this study will be improving our understanding of kidney disease in HIV. It will help us determine the value of screening for kidney disease and the frequency of certain kidney diseases in HIV in our clinic population.

Eligibility

Eligibility

Ages Eligible for Study: 18 Years and older  
Sexes Eligible for Study: All  
Accepts Healthy Volunteers: No  

Criteria

Inclusion Criteria:

  • Adult patients with HIV who are seen by the University of Mississippi Infectious
disease clinic at the Jackson Medical Mall or patient seen at the University of Mississippi Nephrology Clinic.

contacts and locations

Contacts and Locations

Choosing to participate in a study is an important personal decision.Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00392132

Locations

United States, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216-4505

Sponsors and Collaborators

University of Mississippi Medical Center

Investigators

Principal Investigator: Darren W Schmidt, MD University of Mississippi Medical Center
More Information

More Information


Responsible Party: Darren Schmidt, Assistant Professor of Medicine, University of Mississippi Medical Center  
ClinicalTrials.gov Identifier: NCT00392132   History of Changes  
Other Study ID Numbers: UMMC - HIV and CKD  
Study First Received: October 23, 2006  
Last Updated: November 24, 2008  

Keywords provided by University of Mississippi Medical Center:

HIV

Additional relevant MeSH terms:
HIV Infections
Kidney Diseases
Renal Insufficiency
Proteinuria
Renal Insufficiency, Chronic

ClinicalTrials.gov processed this data on October 23, 2017
This information is provided by ClinicalTrials.gov.